The role of positron emission tomography in management of small cell lung cancer

被引：32
|
作者：
Thomson, D. [1 ]
Hulse, P. [2 ]
Lorigan, P. [3 ]
Faivre-Finn, C. [1 ]
机构：
[1] Christie NHS Fdn Trust, Dept Clin Oncol, Manchester M20 4BX, Lancs, England
[2] Christie NHS Fdn Trust, Dept Radiol, Manchester M20 4BX, Lancs, England
[3] Christie NHS Fdn Trust, Dept Med Oncol, Manchester M20 4BX, Lancs, England
来源：
LUNG CANCER | 2011年 / 73卷 / 02期
关键词：
Lung cancer; Small-cell lung cancer; Positron emission tomography; PET; FDG-PET; PET-CT; CLINICAL-PRACTICE GUIDELINES; PHASE-III TRIAL; BODY FDG-PET; RESPONSE EVALUATION; THORACIC RADIOTHERAPY; TNM-CLASSIFICATION; PROGNOSTIC-FACTORS; F-18-FDG PET; DIAGNOSIS; CT;
D O I：
10.1016/j.lungcan.2011.03.013
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Accurate radiological staging of small-cell lung cancer (SCLC) is of paramount importance in selection of individual patients with limited stage disease for potentially curative treatment while avoiding toxic treatment in those with distant metastatic disease. [F-18] flurodeoxy-o-glucose (FDG) positron emission tomography (PET) is an attractive tool for this purpose but there is limited evidence to support its use in the routine staging of SCLC. Whether therapeutic decisions based on FDG-PET imaging should be made remains uncertain. There is only preliminary evidence for use of FDG-PET as a prognostic biomarker, in the assessment of response to treatment and delineation of disease in conformal radiation planning. (C) 2011 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码：121 / 126
页数：6
相关论文
共 50 条
  • [1] The role of positron emission tomography in the management of non-small cell lung cancer
    Behzadi, Abdollah
    Ung, Yee
    Lowe, Val
    Deschamps, Claude
    CANADIAN JOURNAL OF SURGERY, 2009, 52 (03) : 235 - 242
  • [2] Positron emission tomography in the management of non-small cell lung cancer
    Vansteenkiste, JF
    Stroobants, SG
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2004, 18 (01) : 269 - +
  • [3] The role of positron emission tomography for non-small cell lung cancer
    Chang, Albert J.
    Dehdashti, Farrokh
    Bradley, Jeffrey D.
    PRACTICAL RADIATION ONCOLOGY, 2011, 1 (04) : 282 - 288
  • [4] Is there a role for positron emission tomography/computed tomography in the staging of small-cell lung cancer?
    Truong, Mylene T.
    Marom, Edith M.
    CLINICAL LUNG CANCER, 2008, 9 (01) : 8 - 8
  • [5] The role of positron emission tomography in staging of non-small cell lung cancer
    Rankin, Sheila C.
    TARGETED ONCOLOGY, 2008, 3 (03) : 149 - 159
  • [6] The role of positron emission tomography in staging of non-small cell lung cancer
    Sheila C. Rankin
    Targeted Oncology, 2008, 3
  • [7] Role of positron emission tomography in lung cancer
    Miles K.A.
    Cancer Imaging, 2002, 2 (2) : 87 - 89
  • [8] The Role of Positron Emission Tomography-Computed Tomography in the Workup of Non-Small Cell Lung Cancer
    Walter, Martin A.
    JAMA NETWORK OPEN, 2019, 2 (11)
  • [9] Impact of positron emission tomography on the management of patients with small-cell lung cancer - Preliminary experience
    Blum, R
    MacManus, MP
    Rischin, D
    Michael, M
    Ball, D
    Hicks, RJ
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2004, 27 (02): : 164 - 171
  • [10] The role of positron emission tomography (PET) in mediastinal staging of non-small cell lung cancer
    Melek, Huseyin
    Gunluoglu, Mehmet Zeki
    Demir, Adalet
    Akin, Hasan
    Medetoglu, Baris
    Kara, Hasan Volkan
    Olcmen, Aysun
    Dincer, Seyyit Ibrahim
    TUBERKULOZ VE TORAK-TUBERCULOSIS AND THORAX, 2008, 56 (01): : 56 - 63
12345